Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft
ANATOLIAN JOURNAL OF CARDIOLOGY, vol.16, no.2, pp.131-136, 2016 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 16 Issue: 2
- Publication Date: 2016
- Doi Number: 10.5152/akd.2015.5936
- Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.131-136
- Open Archive Collection: AVESIS Open Access Collection
- Kütahya Health Sciences University Affiliated: No
Abstract
Objective: The aim of this study was to evaluate erectile function in males undergoing coronary artery bypass graft (CABG) while on two different adrenoceptor beta-blocker regimens, namely nebivolol and metoprolol. We hypothesize that the negative effects of cardiopulmonary bypass on erectile function may be possibly attenuated by preferring a vasodilating selective beta(1)-blocker, nebivolol, to metoprolol as an anti-ischemic and antiarrhythmic agent in males undergoing CABG.